You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 17, 2025

Sodium lactate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for sodium lactate and what is the scope of patent protection?

Sodium lactate is the generic ingredient in three branded drugs marketed by B Braun, Baxter Hlthcare, and Hospira, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for sodium lactate.

Summary for sodium lactate
US Patents:0
Tradenames:3
Applicants:3
NDAs:5
Drug Master File Entries: 1
Raw Ingredient (Bulk) Api Vendors: 112
Clinical Trials: 89
DailyMed Link:sodium lactate at DailyMed
Recent Clinical Trials for sodium lactate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of California, Los AngelesPHASE2
University of PittsburghPHASE4
Fundacin Cardioinfantil Instituto de CardiologaPHASE4

See all sodium lactate clinical trials

US Patents and Regulatory Information for sodium lactate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira SODIUM LACTATE IN PLASTIC CONTAINER sodium lactate INJECTABLE;INJECTION 018947-001 Sep 5, 1984 DISCN Yes No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
Baxter Hlthcare SODIUM LACTATE 0.167 MOLAR IN PLASTIC CONTAINER sodium lactate INJECTABLE;INJECTION 016692-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
B Braun SODIUM LACTATE 1/6 MOLAR IN PLASTIC CONTAINER sodium lactate INJECTABLE;INJECTION 020004-001 Apr 21, 1992 DISCN No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Market Dynamics and Financial Trajectory for Sodium Lactate

Last updated: August 2, 2025

Introduction

Sodium lactate, a salt of lactic acid, plays a vital role in various pharmaceutical and medical applications. Its increasing utilization across sectors such as pharmaceuticals, cosmetics, food, and sports medicine positions it as an essential compound within the biopharmaceutical supply chain. This report examines the current market dynamics and financial trajectory of sodium lactate, emphasizing key factors influencing demand, supply, regulatory landscape, and economic prospects.

Market Overview

Sodium lactate's global market is projected to exhibit steady growth owing to its multifaceted applications in fluid retention, electrolyte replenishment, skin hydration, and pH regulation. The increasing prevalence of dehydration-related ailments, rising surgical procedures, and expanding cosmetic industry are primary drivers of growth. The global sodium lactate market was valued at approximately USD 250 million in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of around 6-8% from 2023 to 2030.

Key Market Drivers

1. Rising Pharmaceutical and Medical Applications

Sodium lactate is extensively used in intravenous (IV) therapy as a vehicle for electrolyte and fluid replacement. With an aging population worldwide and increasing incidences of chronic illnesses such as dehydration, metabolic acidosis, and electrolyte imbalances, demand from healthcare facilities continues to grow. Additionally, sodium lactate's role in wound care and surgical procedures further enhances its importance within clinical settings.

2. Expanding Cosmetic and Personal Care Sector

The cosmetic industry utilizes sodium lactate as a humectant and skin conditioning agent due to its moisturizing properties and safety profile. The surge in demand for natural and gentle skincare products bolsters sodium lactate's market penetration.

3. Food Industry Utilization

Sodium lactate functions as a preservative and flavor enhancer in processed foods. The trend toward clean-label and additive-free foods has led manufacturers to adopt sodium lactate as a natural additive, further stimulating demand.

4. Sports Nutrition and Fitness Industry

Its application in sports drinks and rehydration solutions leverages sodium lactate's efficacy in maintaining electrolyte balance, particularly in post-exercise recovery.

5. Regulatory Approvals and Support

Regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Food Safety Authority (EFSA) regard sodium lactate as safe when used within prescribed limits, facilitating its widespread acceptance in consumer products and parenteral formulations.

Supply Chain and Production Landscape

1. Raw Material Availability

Sodium lactate is predominantly produced via microbial fermentation of carbohydrate sources such as corn starch, sugar beets, or cane sugar. The abundance of these feedstocks ensures a stable raw material supply.

2. Manufacturing Capacity and Key Players

Major producers include CG Chemikalien, SP Group, and MERCK KGaA, operating extensive fermentation and chemical synthesis facilities globally. The industry has seen recent investments aimed at expanding production capacities to meet rising demand.

3. Cost Dynamics

Production costs are driven mainly by fermentation technology efficiencies, raw material prices, and energy costs. Innovations in bioprocessing are continually reducing production expenses, allowing competitive pricing.

Market Challenges

1. Stringent Regulatory Environment

The pharmaceutical and cosmetic sectors face rigorous testing and approval processes, potentially delaying product launches and increasing compliance costs.

2. Market Saturation and Competition

As the market matures, especially in developed regions, growth is moderated by saturation and willingness-to-pay constraints. Emerging markets present growth opportunities but often grapple with infrastructural limitations.

3. Price Fluctuations in Raw Materials

Volatility in raw material prices, especially due to agricultural commodity fluctuations, can impact profit margins for manufacturers.

Financial Trajectory and Investment Outlook

1. Revenue Projections

The steady CAGR of approximately 6-8% suggests a robust revenue trajectory for sodium lactate over the coming decade. Driven predominantly by healthcare and cosmetic demand, revenues are expected to surpass USD 450 million globally by 2030.

2. Market Segmentation and Profitability

  • Pharmaceutical Segment: Highest margins due to regulatory approval and high clinical requisites.
  • Cosmetics & Personal Care: Moderate margins with significant volume potential.
  • Food Industry: Competitive pricing but steady demand.

3. Investment Opportunities

Investors should consider the following sectors within sodium lactate markets:

  • Biomanufacturing Expansion: Opportunities exist in companies investing in fermentation process improvements.
  • Product Formulation Innovations: Development of stabilized, high-purity sodium lactate variants can command premium pricing.
  • Emerging Markets Penetration: Growth in Asia-Pacific, Latin America, and Africa offers promising avenues due to rising healthcare and cosmetic sectors.

4. Risks and Mitigation

Financial risk factors include raw material price volatility and regulatory hurdles. Diversification of supply sources and investment in R&D can mitigate these risks.

Regulatory and Quality Standards Impact

The growing stringency of regulatory standards globally underscores the importance of maintaining high-quality manufacturing processes. Certifications such as ISO, cGMP, and adherence to pharmacopeial standards (USP, EP, JP) will influence market access and pricing strategies.

Concluding Insights

Sodium lactate's future is buoyed by its critical applications across healthcare, cosmetics, food, and sports industries. Innovation in fermentation technology, strategic capacity expansion, and geographic diversification will be pivotal to capitalizing on rising demand. Manufacturers and investors should monitor regulatory developments and raw material supply trends to optimize their market strategies.


Key Takeaways

  • The global sodium lactate market is projected to grow at a CAGR of 6-8%, driven by increasing pharmaceutical needs and expanding cosmetic usage.
  • Major demand centers include North America, Europe, and Asia-Pacific, with emerging markets presenting growth opportunities.
  • Supply chain resilience hinges on stable raw material supply and advancements in bioproduction technologies.
  • Regulatory compliance remains a critical factor influencing market entry, product development, and pricing.
  • Strategic investments in capacity expansion and product innovation can position companies for sustained growth amidst market saturation in mature regions.

FAQs

1. What are the primary applications of sodium lactate in the pharmaceutical industry?
Sodium lactate is mainly used in IV fluid therapy, wound healing, and surgical solutions due to its electrolyte-replenishing and pH-buffering properties.

2. How does the cosmetic industry influence the demand for sodium lactate?
Its role as a humectant and skin moisturizer in skincare formulations fosters increased demand, especially amid trends favoring natural and gentle ingredients.

3. What factors could inhibit the growth of the sodium lactate market?
Regulatory delays, raw material price volatility, and market saturation in developed regions are primary challenges.

4. Which regions are emerging as new markets for sodium lactate?
Asia-Pacific and parts of Latin America are experiencing significant growth owing to increasing healthcare infrastructure and cosmetic consumption.

5. What technological advancements can impact sodium lactate production?
Improvements in microbial fermentation efficiency and bioprocessing automation can reduce costs and enhance product quality, positively affecting profitability.


Sources:

[1] MarketsandMarkets. Global Sodium Lactate Market Report, 2023.
[2] Frost & Sullivan. Pharmaceutical Excipient Market Dynamics, 2022.
[3] European Food Safety Authority (EFSA). Safety Assessment of Sodium Lactate, 2021.
[4] Industry Reports. Biotech Manufacturing Trends, 2022.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.